We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · April 26, 2018

Fibroblast Growth Factor 23 May Be a Prognostic Indicator in Acute Coronary Syndrome

JAMA Cardiology


Additional Info

JAMA Cardiology
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial
JAMA Cardiol 2018 Apr 18;[EPub Ahead of Print], BA Bergmark, JA Udell, DA Morrow, et al

Further Reading